Answer in brief
CVE-2026-66832 records a Unknown severity vulnerability in Mira Hormone Monitor, Mira Android App Use of GET request method with sensitive query strings. The current sources do not mark it as known exploited. The current feed maps Quanovate Tech Inc. (operating as Mira / Mira Care)/Mira Android App (generic), Quanovate Tech Inc. (operating as Mira / Mira Care)/Mira Firmware (generic). Check affected ranges and fixed versions before updating.
Analysis pending evidence review
HOL Guard separates source facts from reviewed analysis. See the methodology.
A CVSS score is not reported in the current record. The current sources do not mark it as known exploited. Treat this as a source-backed prioritization signal, not a statement about your environment.
Analysis status
Analysis pending evidence review
Factual feed record only; HOL analysis is not approved for indexing. Read the methodology.
The current feed maps Quanovate Tech Inc. (operating as Mira / Mira Care)/Mira Android App (generic), Quanovate Tech Inc. (operating as Mira / Mira Care)/Mira Firmware (generic). Check affected ranges and fixed versions before updating.
| Package | Affected range | Fixed version |
|---|---|---|
| Quanovate Tech Inc. (operating as Mira / Mira Care)/Mira Android Appgeneric | 4.5.15.4 | Not reported |
| Quanovate Tech Inc. (operating as Mira / Mira Care)/Mira Firmwaregeneric | 1.7.1.47 | Not reported |
Published upstream
Aug 11, 2026
Evidence: source:cvelist:source_dates:source-dates:recordSource modified
Aug 11, 2026
Evidence: source:cvelist:source_dates:source-dates:recordFirst seen by HOL
Aug 11, 2026
When the Mira Android app opens in-app WebView content (e.g., shop redirect flows), the user's live session token is appended to the URL as a query string parameter, and a persistent user identifier is included in the WebView's User-Agent header. Both are then transmitted to third-party web properties, referrer logs, and any JavaScript running in the WebView context.
Quoted source text, attributed separately from HOL analysis.
Answer in brief
CVE-2026-66832 records a Unknown severity vulnerability in Mira Hormone Monitor, Mira Android App Use of GET request method with sensitive query strings. The current sources do not mark it as known exploited. The current feed maps Quanovate Tech Inc. (operating as Mira / Mira Care)/Mira Android App (generic), Quanovate Tech Inc. (operating as Mira / Mira Care)/Mira Firmware (generic). Check affected ranges and fixed versions before updating.
Analysis pending evidence review
HOL Guard separates source facts from reviewed analysis. See the methodology.
A CVSS score is not reported in the current record. The current sources do not mark it as known exploited. Treat this as a source-backed prioritization signal, not a statement about your environment.
Analysis status
Analysis pending evidence review
Factual feed record only; HOL analysis is not approved for indexing. Read the methodology.
The current feed maps Quanovate Tech Inc. (operating as Mira / Mira Care)/Mira Android App (generic), Quanovate Tech Inc. (operating as Mira / Mira Care)/Mira Firmware (generic). Check affected ranges and fixed versions before updating.
| Package | Affected range | Fixed version |
|---|---|---|
| Quanovate Tech Inc. (operating as Mira / Mira Care)/Mira Android Appgeneric | 4.5.15.4 | Not reported |
| Quanovate Tech Inc. (operating as Mira / Mira Care)/Mira Firmwaregeneric | 1.7.1.47 | Not reported |
Published upstream
Aug 11, 2026
Evidence: source:cvelist:source_dates:source-dates:recordSource modified
Aug 11, 2026
Evidence: source:cvelist:source_dates:source-dates:recordFirst seen by HOL
Aug 11, 2026
When the Mira Android app opens in-app WebView content (e.g., shop redirect flows), the user's live session token is appended to the URL as a query string parameter, and a persistent user identifier is included in the WebView's User-Agent header. Both are then transmitted to third-party web properties, referrer logs, and any JavaScript running in the WebView context.
Quoted source text, attributed separately from HOL analysis.